You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 12, 2024

Litigation Details for Astellas Institute for Regenerative Medicine v. ImStem Biotechnology, Inc. (D. Mass. 2017)


✉ Email this page to a colleague

« Back to Dashboard


Small Molecule Drugs cited in Astellas Institute for Regenerative Medicine v. ImStem Biotechnology, Inc.
The small molecule drugs covered by the patents cited in this case are ⤷  Sign Up and ⤷  Sign Up .

Details for Astellas Institute for Regenerative Medicine v. ImStem Biotechnology, Inc. (D. Mass. 2017)

Date Filed Document No. Description Snippet Link To Document
0000-00-00 External link to document
2020-12-03 244 Proposed Findings of Fact use for a pre-existing compound. See U.S. Patent No. 6,469,012. The compound had been known for years in…basis for the patent applications that later become the ‘321 patent and the ‘956 patent.19 See TX-48;…the ‘551 patent, that they be added to the ‘321 patent, Dr. Wang be added to the ’956 patent, and that… unjust enrichment.”). 4 U.S. Patent No. 8,961,956. 5 U.S. Patent No. 8,962,321. …), which would later mature into the ‘321 Patent, and Patent Cooperation Treaty Application No. PCT/US2012 External link to document
2020-12-15 247 Exhibit Redline of Defendants' Corrected FOF COL use for a pre-existing compound. See U.S. Patent No. 6,469,012. The compound had been known for years in…basis for the patent applications that later become the ‘321 patent and the ‘956 patent.19 See TX-48;…the ‘551 patent, that they be added to the ‘321 patent, Dr. Wang be added to the ’956 patent, and that… unjust enrichment.”). 4 U.S. Patent No. 8,961,956. 5 U.S. Patent No. 8,962,321. …), which would later mature into the ‘321 Patent, and Patent Cooperation Treaty Application No. PCT/US2012 External link to document
2018-03-16 28 use for a pre-existing compound. See U.S. Patent No. 6,469,012. The underlying compound had been known … inventors on the face of U.S. Patent No. 8,961,956 (the “‘956 patent”) includes everyone who contributed… of the ‘956 patent. He should have been listed among the inventors when the ‘956 patent’s application…invalidate the very patent at issue. In their zeal to keep Dr. Wang off of the ‘956 patent they have attacked… Claimed in the ‘956 Patent The central conception of the ‘956 patent is the idea of using External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.